2509 — Qyuns Therapeutics Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$6.02bn
- HK$5.99bn
Annual cashflow statement for Qyuns Therapeutics Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -427 | -312 | -521 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 259 | 29.8 | 138 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 19.6 | 26.9 | 50 |
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -123 | -225 | -301 |
| Capital Expenditures | -58.9 | -22.8 | -7.95 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -188 | 17.1 | 251 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -247 | -5.7 | 243 |
| Financing Cash Flow Items | 284 | -15.9 | -15.2 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 281 | 211 | 61.2 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -91.2 | -4.96 | 3.21 |